ARCXF

ArcelorMittal

OTC · Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens) · CIK 0001243429
$0.0587 0.00%
Vol
SEC Reports13

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

13 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 2 mixed, 10 neutral. Avg impact: 3.2/10.
NEUTRAL 6-K 2/10
ArcelorMittal filed a Form 6-K on June 3, 2026, disclosing a routine share transaction by a Designat
Jun 3, 2026
NEUTRAL 6-K 2/10
ArcelorMittal filed a Form 6-K disclosing a routine share transaction notification by a designated p
May 27, 2026
BULLISH 6-K 5/10
ArcelorMittal sold ~23.9M Vallourec shares (~10% of outstanding) at EUR 24.00/share, raising ~US$667
May 19, 2026
NEUTRAL 6-K 4/10
ArcelorMittal issued $1 billion of 5.375% senior unsecured notes due 2036 via a sixth supplemental i
May 19, 2026
NEUTRAL 6-K 2/10
ArcelorMittal filed a Form 6-K on May 13, 2026, disclosing a routine share transaction by a Designat
May 14, 2026
NEUTRAL 424B5 4/10
ArcelorMittal is issuing $1,000,000,000 in 5.375% senior unsecured notes due 2036, with net proceeds
May 13, 2026
NEUTRAL 6-K 4/10
ArcelorMittal priced a $1,000,000,000 senior unsecured note offering (5.375% due 2036) on May 12, 20
May 13, 2026
NEUTRAL 424B5 3/10
ArcelorMittal is offering an undisclosed amount of senior unsecured notes due at an undisclosed date
May 12, 2026
MIXED 6-K 5/10
ArcelorMittal reported Q1 2026 results showing sequential improvement: sales rose 3.2% QoQ to $15.5B
May 12, 2026
NEUTRAL 6-K 2/10
ArcelorMittal announced the results of its Annual and Extraordinary General Meetings, where sharehol
May 6, 2026
MIXED 6-K 5/10
ArcelorMittal released its 2025 Sustainability Report highlighting a 47.7% reduction in absolute Sco
Apr 23, 2026
NEUTRAL 6-K 2/10
ArcelorMittal announced its Annual and Extraordinary General Meeting of shareholders on May 5, 2026,
Apr 3, 2026
NEUTRAL 6-K 2/10
ArcelorMittal announced the publication of its 2025 statutory financial statements for the parent co
Mar 30, 2026

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Oct 2012): 80% buy across 5 analysts — 2 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Oct 4, 2012 Morgan Stanley INITIATE Underweight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Nov 1, 20242210080%
Oct 1, 20242210080%
Sep 1, 20242210080%
Aug 1, 20242210080%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.